REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 75 filers reported holding REPARE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,995,290 | +14.2% | 165,173 | 0.0% | 0.92% | +15.5% |
| Q2 2023 | $1,747,530 | +7.7% | 165,173 | +0.2% | 0.80% | -39.5% |
| Q1 2023 | $1,622,518 | -33.1% | 164,890 | 0.0% | 1.32% | -8.2% |
| Q4 2022 | $2,425,532 | -34.3% | 164,890 | -45.8% | 1.44% | -31.7% |
| Q3 2022 | $3,690,000 | +72.8% | 304,181 | +99.3% | 2.11% | +63.5% |
| Q2 2022 | $2,135,000 | +4.6% | 152,600 | +6.4% | 1.29% | -0.7% |
| Q1 2022 | $2,042,000 | +122.7% | 143,375 | +229.6% | 1.30% | +77.8% |
| Q4 2021 | $917,000 | -3.2% | 43,497 | +20.5% | 0.73% | +16.4% |
| Q3 2021 | $947,000 | – | 36,104 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $32,989,176 | 13.80% |
| CHI Advisors LLC | 2,800,126 | $41,189,854 | 10.97% |
| MPM BioImpact LLC | 1,639,849 | $24,122,179 | 6.26% |
| BVF INC/IL | 8,291,988 | $121,975,143 | 5.15% |
| Deep Track Capital, LP | 2,727,606 | $40,123,084 | 1.68% |
| Redmile Group, LLC | 2,684,396 | $39,487,465 | 1.62% |
| HighVista Strategies LLC | 164,890 | $2,425,532 | 1.44% |
| Orbimed Advisors | 3,322,488 | $48,873,798 | 0.94% |
| Artal Group S.A. | 700,000 | $10,297 | 0.58% |
| HARBOR CAPITAL ADVISORS, INC. | 34,572 | $508,554 | 0.49% |